CombiGene is preparing for clinical studies together with partner Spark Therapeutics. BioStock contacted the company's Chairman of the Board, Bert Junno, to learn more about the company and to find out what will be discussed at the upcoming Annual General Meeting on May 19. Among other things, we get to know more about the details of the proposed incentive programme.

Read the full interview with Bert Junno at biostock.se:

https://www.biostock.se/en/2022/04/combigenes-chairman-of-the-board-comments-on-the-future/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

https://news.cision.com/combigene/r/biostock-combigene-s-chairman-of-the-board-comments-on-the-future,c3556922

(c) 2022 Cision. All rights reserved., source Press Releases - English